All Stories

  1. Durability of Humoral Responses after an Adapted SARS-CoV-2 mRNA Vaccine Dose in Hemodialysis Patients
  2. Multi-detector fusion and Bayesian smoothing for tracking viral and chromatin structures
  3. Cutting edges in the hepatitis B virus genome: How RNA splicing is involved in modulating virus ultrastructure to promote infection
  4. Cell‐Penetrating Peptide‐Bismuth Bicycles**
  5. Cell‐Penetrating Peptide‐Bismuth Bicycles**
  6. Zika virus remodelled ER membranes contain proviral factors involved in redox and methylation pathways
  7. SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle
  8. BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study
  9. Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus
  10. Structural conservation of HBV-like capsid proteins over hundreds of millions of years despite the shift from non-enveloped to enveloped life-style
  11. Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication
  12. Multi-Channel Colocalization Analysis and Visualization of Viral Proteins in Fluorescence Microscopy Images
  13. Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus
  14. A snapshot of protein trafficking in SARS‐CoV‐2 infection
  15. SARS-CoV-2 nsp3-4 suffice to form a pore shaping replication organelles
  16. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen
  17. Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread
  18. Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy
  19. Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrier
  20. Genome-Wide CRISPR Screen Identifies RACK1 as a Critical Host Factor for Flavivirus Replication
  21. The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein
  22. Determinants in Nonstructural Protein 4A of Dengue Virus Required for RNA Replication and Replication Organelle Biogenesis
  23. Dengue virus is sensitive to inhibition prior to productive replication
  24. TLR3 Activation by Zika Virus Stimulates Inflammatory Cytokine Production Which Dampens the Antiviral Response Induced by RIG-I-Like Receptors
  25. Can we predict antibody responses in SARS-CoV-2? A cohort analysis
  26. A Versatile Reporter System To Monitor Virus-Infected Cells and Its Application to Dengue Virus and SARS-CoV-2
  27. Dimer Organization of Membrane‐Associated NS5A of Hepatitis C Virus as Determined by Highly Sensitive 1 H‐Detected Solid‐State NMR
  28. Dimer Organization of Membrane‐Associated NS5A of Hepatitis C Virus as Determined by Highly Sensitive 1 H‐Detected Solid‐State NMR
  29. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography
  30. A Novel Cis-Acting RNA Structural Element Embedded in the Core Coding Region of the Hepatitis C Virus Genome Directs Internal Translation Initiation of the Overlapping Core+1 ORF
  31. A versatile reporter system to monitor virus infected cells and its application to dengue virus and SARS-CoV-2
  32. SARS-CoV-2 structure and replication characterized byin situcryo-electron tomography
  33. Proton‐Detected Solid‐State NMR of the Cell‐Free Synthesized α‐Helical Transmembrane Protein NS4B from Hepatitis C Virus
  34. Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation
  35. A Recurrent Neural Network for Particle Tracking in Microscopy Images Using Future Information, Track Hypotheses, and Multiple Detections
  36. ER-shaping atlastin proteins act as central hubs to promote flavivirus replication and virion assembly
  37. RACK1 mediates rewiring of intracellular networks induced by hepatitis C virus infection
  38. Prodrug Activation by a Viral Protease: Evaluating Combretastatin Peptide Hybrids To Selectively Target Infected Cells
  39. A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle
  40. Synthesis, Biological Evaluation, and Molecular Docking of Combretastatin and Colchicine Derivatives and their hCE1‐Activated Prodrugs as Antiviral Agents
  41. Discovery of highly divergent lineages of plant-associated astro-like viruses sheds light on the emergence of potyviruses
  42. The Role of Tissue Oxygen Tension in Dengue Virus Replication
  43. mRNAs biotinylated within the 5′ cap and protected against decapping: new tools to capture RNA–protein complexes
  44. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro
  45. A Reverse Genetics System for Zika Virus Based on a Simple Molecular Cloning Strategy
  46. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
  47. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis
  48. Glycine-zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles
  49. Optimization of Substrate-Analogue Furin Inhibitors
  50. Membrane alterations induced by nonstructural proteins of human norovirus
  51. Hepatitis C Virus Replication Depends on Endosomal Cholesterol Homeostasis
  52. Host-directed therapies for bacterial and viral infections
  53. Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses
  54. Genome packaging of reovirus is mediated by the scaffolding property of the microtubule network
  55. Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model
  56. Overall Structural Model of NS5A Protein from Hepatitis C Virus and Modulation by Mutations Confering Resistance of Virus Replication to Cyclosporin A
  57. Erratum for Roth et al., “Flavivirus Infection Uncouples Translation Suppression from Cellular Stress Responses”
  58. Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity
  59. Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism
  60. Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening
  61. Ultrastructural Characterization of Zika Virus Replication Factories
  62. Flavivirus Infection Uncouples Translation Suppression from Cellular Stress Responses
  63. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
  64. Chronic viral hepatitis and its association with liver cancer
  65. Editorial: An expanded view of viruses
  66. Peptide–Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology
  67. The quest for host targets to combat dengue virus infections
  68. Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin
  69. Hepatitis C Virus—From Discovery to Cure
  70. Corrigendum: Conserved RNA secondary structures and long-range interactions in hepatitis C viruses
  71. Dengue Virus Perturbs Mitochondrial Morphodynamics to Dampen Innate Immune Responses
  72. Reovirus intermediate subviral particles constitute a strategy to infect intestinal epithelial cells by exploiting TGF-β dependent pro-survival signaling
  73. A Slow Maturation Process Renders Hepatitis B Virus Infectious
  74. Endoplasmic Reticulum: The Favorite Intracellular Niche for Viral Replication and Assembly
  75. Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus
  76. Correlative light and electron microscopy methods for the study of virus-cell interactions
  77. Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6)
  78. Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation
  79. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys
  80. A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication
  81. P147: A phenotypic NS3-protease inhibitor resistance assay to characterize resistance-associated mutations in patients
  82. P117: Hepatitis C Virus mediates NRG1-dependent down-regulation of ErbB3, thereby modifies ErbB receptor family composition at the cell surface
  83. P119: Hepatitis C virus inhibits IL-1 β -induced Iк Bζ expression and thereby antagonizes mechanisms which may affect cell proliferation
  84. P096: Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication via blockage of membranous web formation
  85. P118: The Hepatitis C Virus (HCV) facilitates CXCR2 ligand expression in response to the Epidermal Growth Factor (EGF) and is able to induce the EGF production by an autocrine circuit in its host cell
  86. Dengue Virus Inhibition of Autophagic Flux and Dependency of Viral Replication on Proteasomal Degradation of the Autophagy Receptor p62
  87. Conserved RNA secondary structures and long-range interactions in hepatitis C viruses
  88. A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication
  89. Hepatitis C virus infection inhibits P-body granule formation in human livers
  90. Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody
  91. A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
  92. A monocytic detour to replicate patient‐derived hepatitis C virus in hepatoma cells and its use for phenotypic analyses
  93. Expression of the Novel Hepatitis C Virus Core+1/ARF Protein in the Context of JFH1-Based Replicons
  94. A sensor at the lipid‐protein interface: Lipid peroxidation controls hepatitis C virus replication
  95. Identification of HNRNPK as Regulator of Hepatitis C Virus Particle Production
  96. Wheat germ cell-free expression: Two detergents with a low critical micelle concentration allow for production of soluble HCV membrane proteins
  97. Novel Dengue Virus NS2B/NS3 Protease Inhibitors
  98. Aminoterminal Amphipathic α-Helix AH1 of Hepatitis C Virus Nonstructural Protein 4B Possesses a Dual Role in RNA Replication and Virus Production
  99. Daclatasvir-Like Inhibitors of NS5A Block Early Biogenesis of Hepatitis C Virus–Induced Membranous Replication Factories, Independent of RNA Replication
  100. Hepatitis C Virus RNA Replication and Assembly: Living on the Fat of the Land
  101. Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region
  102. Apolipoprotein E Likely Contributes to a Maturation Step of Infectious Hepatitis C Virus Particles and Interacts with Viral Envelope Glycoproteins
  103. The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production
  104. Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor
  105. Membranous Replication Factories Induced by Plus-Strand RNA Viruses
  106. Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
  107. Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin
  108. Inhibition of HCV Replication by Cyclophilin Antagonists Is Linked to Replication Fitness and Occurs by Inhibition of Membranous Web Formation
  109. Heterologous Src Homology 4 Domains Support Membrane Anchoring and Biological Activity of HIV-1 Nef
  110. Targets for Antiviral Therapy of Hepatitis C
  111. Dengue Virus- and Hepatitis C Virus-Induced Replication and Assembly Compartments: the Enemy Inside--Caught in the Web
  112. Perilipin discerns chronic from acute hepatocellular steatosis
  113. Revisiting Dengue Virus–Host Cell Interaction
  114. On the History of Hepatitis C Virus Cell Culture Systems
  115. Thiazolidinone–Peptide Hybrids as Dengue Virus Protease Inhibitors with Antiviral Activity in Cell Culture
  116. Hepatitis C: A mouse at the end of the tunnel
  117. Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines
  118. Membrane undulation induced by NS4A of Dengue virus: a molecular dynamics simulation study
  119. Replication Vesicles are Load- and Choke-Points in the Hepatitis C Virus Lifecycle
  120. Morphological and Biochemical Characterization of the Membranous Hepatitis C Virus Replication Compartment
  121. The Interactomes of Influenza Virus NS1 and NS2 Proteins Identify New Host Factors and Provide Insights for ADAR1 Playing a Supportive Role in Virus Replication
  122. Hepatitis C virus core+1/ARF protein decreases hepcidin transcription through an AP1 binding site
  123. Evidence for Novel Hepaciviruses in Rodents
  124. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
  125. The Lipid Kinase Phosphatidylinositol-4 Kinase III Alpha Regulates the Phosphorylation Status of Hepatitis C Virus NS5A
  126. Three-Dimensional Architecture of Tick-Borne Encephalitis Virus Replication Sites and Trafficking of the Replicated RNA
  127. Nuclear Localization of Dengue Virus Nonstructural Protein 5 Does Not Strictly Correlate with Efficient Viral RNA Replication and Inhibition of Type I Interferon Signaling
  128. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B
  129. Factors That Determine the Antiviral Efficacy of HCV-Specific CD8+ T Cells Ex Vivo
  130. Virion Assembly and Release
  131. Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
  132. Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
  133. Adaptive Immune Responses in Hepatitis C Virus Infection
  134. Animal Models for Hepatitis C
  135. Cell Culture Systems for Hepatitis C Virus
  136. Hepatitis C Virus Proteins: From Structure to Function
  137. Hepatitis C Virus RNA Replication
  138. Hepatitis C Virus RNA Translation
  139. Hepatitis C Virus Replicons Volume 3 and 4
  140. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN)
  141. Innate Immune Responses to Hepatitis C Virus
  142. The Origin of Hepatitis C Virus
  143. Treatment of Chronic Hepatitis C: Current and Future
  144. Low Oxygen Tension Enhances Hepatitis C Virus Replication
  145. Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication
  146. A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein
  147. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication
  148. TCR-Redirected Human T Cells Inhibit Hepatitis C Virus Replication: Hepatotoxic Potential Is Linked to Antigen Specificity and Functional Avidity
  149. Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
  150. Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells
  151. Persistence of HCV in Quiescent Hepatic Cells Under Conditions of an Interferon-Induced Antiviral Response
  152. MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles
  153. Viral immune modulators perturb the human molecular network by common and unique strategies
  154. A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes
  155. Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies
  156. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
  157. Persistent intracellular pathogens
  158. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients
  159. miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells
  160. Promotion of Hepatocellular Carcinoma by Hepatitis C Virus
  161. New targets for antiviral therapy of chronic hepatitis C
  162. Normalizing for individual cell population context in the analysis of high-content cellular screens
  163. Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
  164. Mouse Hepatic Cells Support Assembly of Infectious Hepatitis C Virus Particles
  165. Exploitation of cellular pathways by Dengue virus
  166. Molecular Mechanism of Signal Perception and Integration by the Innate Immune Sensor Retinoic Acid-inducible Gene-I (RIG-I)
  167. A Concerted Action of Hepatitis C Virus P7 and Nonstructural Protein 2 Regulates Core Localization at the Endoplasmic Reticulum and Virus Assembly
  168. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo
  169. Die molekularen Mechanismen der Replikation des Hepatitis C Virus – Implikationen für die Entwicklung antiviraler Wirkstoffe
  170. Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture
  171. Domain 3 of NS5A Protein from the Hepatitis C Virus Has Intrinsic α-Helical Propensity and Is a Substrate of Cyclophilin A
  172. Interleukin‐32: A new proinflammatory cytokine involved in hepatitis C virus‐related liver inflammation and fibrosis
  173. NS4B Self-Interaction through Conserved C-Terminal Elements Is Required for the Establishment of Functional Hepatitis C Virus Replication Complexes
  174. C-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: A prerequisite for replication
  175. Hepatitis c virus and host cell lipids: An intimate connection
  176. Assembly of infectious hepatitis C virus particles
  177. A Comprehensive Structure-Function Comparison of Hepatitis C Virus Strain JFH1 and J6 Polymerases Reveals a Key Residue Stimulating Replication in Cell Culture across Genotypes
  178. Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome
  179. Recruitment and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for Integrity of the Membranous Replication Compartment
  180. Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly
  181. Experimental models to study the immunobiology of hepatitis C virus
  182. Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus
  183. DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
  184. New Insights into Structure and Replication of the Hepatitis C Virus and Clinical Implications
  185. Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes
  186. A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach
  187. Detecting host factors involved in virus infection by observing the clustering of infected cells in siRNA screening images
  188. Hepatitis C virus replication cycle
  189. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development
  190. Role of Annexin A2 in the Production of Infectious Hepatitis C Virus Particles
  191. Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell Line
  192. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response
  193. Role of RNA Structures in Genome Terminal Sequences of the Hepatitis C Virus for Replication and Assembly
  194. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A
  195. Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation
  196. Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
  197. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication
  198. Reconstructing signaling pathways from RNAi data using probabilistic Boolean threshold networks
  199. Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations
  200. Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B
  201. Investigation of a role for lysine residues in non-structural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly
  202. Analysis of CD8+ T-Cell–Mediated Inhibition of Hepatitis C Virus Replication Using a Novel Immunological Model
  203. Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites
  204. Single-cell-based image analysis of high-throughput cell array screens for quantification of viral infection
  205. Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference
  206. Moving closer to a mouse model for hepatitis C
  207. Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase
  208. Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins
  209. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune response
  210. Hepatitis C virus replicons: dinosaurs still in business?
  211. Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion
  212. Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films
  213. Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly
  214. Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and Replication
  215. Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors
  216. Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles
  217. Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization
  218. Molecular aspects of Dengue virus replication
  219. Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly
  220. Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR
  221. 18 BILE ACIDS ENHANCE GENOTYPE 1 HEPATITIS C VIRUS REPLICATION
  222. 607 NEUTRALIZING HOST RESPONSES IN HEPATITIS C VIRUS INFECTION TARGET VIRAL ENTRY AT POST-BINDING STEPS AND MEMBRANE FUSION
  223. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81
  224. The Lipid Droplet Binding Domain of Hepatitis C Virus Core Protein Is a Major Determinant for Efficient Virus Assembly
  225. Erratum
  226. Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant
  227. The lipid droplet is an important organelle for hepatitis C virus production
  228. A Tribute to a Colleague
  229. Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture
  230. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy
  231. Hepatitis viruses in the XXI century
  232. Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions
  233. Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes
  234. The Cyclophilin Inhibitor Debio-025 is a Potent Inhibitor of Hepatitis C Virus Replication in vitro With a Unique Resistance Profile
  235. Identification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase Chimeras
  236. The Non-structural Protein 4A of Dengue Virus Is an Integral Membrane Protein Inducing Membrane Alterations in a 2K-regulated Manner
  237. Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes
  238. euHCVdb: the European hepatitis C virus database
  239. Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus
  240. The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells
  241. Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′-C-Methylcytidine, the Active Component of Valopicitabine
  242. The Hepatitis C Virus RNA 3′-Untranslated Region Strongly Enhances Translation Directed by the Internal Ribosome Entry Site
  243. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b
  244. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture
  245. HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells
  246. Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses
  247. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
  248. High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI
  249. From Structure to Function: New Insights into Hepatitis C Virus RNA Replication
  250. 417 Subgenomic hepatitis C replicon deriving from a clinical isolate with virologic non-response to IFN-based therapy and IFN resistance in vitro
  251. Subcellular Localization and Membrane Topology of the Dengue Virus Type 2 Non-structural Protein 4B
  252. Relation between viral fitness and immune escape within the hepatitis C virus protease
  253. The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practice
  254. O.137 HDL inhibits neutralisation by HCV antibodies via a ternary interaction with the scavenger receptor BI
  255. O.171 HDL inhibits HCV neutralisation by CD81-NOB antibodies by stimulating cell entry through activation of the scavenger receptor BI
  256. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replicationin vitro
  257. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
  258. O.067 Hepatitis C virus: Virology, immunology, natural history, treatment
  259. Quantitative Analysis of the Hepatitis C Virus Replication Complex
  260. Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line
  261. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
  262. Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication
  263. Erratum: Corrigendum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
  264. The hepatitis C virus replicon system: From basic research to clinical application
  265. Efficient hepatitis C virus cell culture system: What a difference the host cell makes
  266. Hepatitis C Virus-Replicating Hepatocytes Induce Fibrogenic Activation of Hepatic Stellate Cells
  267. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
  268. Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion
  269. Mutational Analysis of Hepatitis C Virus Nonstructural Protein 5A: Potential Role of Differential Phosphorylation in RNA Replication and Identification of a Genetically Flexible Domain
  270. Efficient Rescue of Hepatitis C Virus RNA Replication by trans-Complementation with Nonstructural Protein 5A
  271. Kissing-Loop Interaction in the 3′ End of the Hepatitis C Virus Genome Essential for RNA Replication
  272. Membrane Association of the RNA-Dependent RNA Polymerase Is Essential for Hepatitis C Virus RNA Replication
  273. Interferon type I gene expression in chronic hepatitis C
  274. Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A
  275. Targeting of Hepatitis C Virus Core Protein to Mitochondria through a Novel C-Terminal Localization Motif
  276. Application of the trak-C? HCV core assay for monitoring antiviral activity in HCV replication systems
  277. Alternative Approaches for Efficient Inhibition of Hepatitis C Virus RNA Replication by Small Interfering RNAs
  278. Novel Insights into Hepatitis C Virus Replication and Persistence
  279. Replication of the hepatitis C virus in cell culture
  280. A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C
  281. Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons
  282. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-α
  283. Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture
  284. Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein
  285. The Hepatitis C Virus RNA-Dependent RNA Polymerase Membrane Insertion Sequence Is a Transmembrane Segment
  286. Hepatitis C virus replicons: potential role for drug development
  287. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees
  288. Genetic Analysis of Sequences in the 3′ Nontranslated Region of Hepatitis C Virus That Are Important for RNA Replication
  289. Serum versus intrahepatic HCV RNA and liver histology
  290. Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture
  291. Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs
  292. Functional Properties of a Monoclonal Antibody Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase
  293. Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA Replication
  294. Oral immunization with HCV-NS3—transformed Salmonella: Induction of HCV-specific CTL in a transgenic mouse model
  295. Novel cell culture systems for the hepatitis C virus
  296. Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations
  297. Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs
  298. Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation
  299. Replication of the hepatitis C virus
  300. Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
  301. The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy
  302. Selective Stimulation of Hepatitis C Virus and Pestivirus NS5B RNA Polymerase Activity by GTP
  303. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum
  304. Biochemical and Kinetic Analyses of NS5B RNA-Dependent RNA Polymerase of the Hepatitis C Virus
  305. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
  306. Determinants of Substrate Specificity in the NS3 Serine Proteinase of the Hepatitis C Virus
  307. Candidate Targets for Hepatitis C Virus-Specific Antiviral Therapy
  308. In VitroStudies on the Activation of the Hepatitis C Virus NS3 Proteinase by the NS4A Cofactor
  309. An in Vitro Assay for Hepatitis C Virus NS3 Serine Proteinase
  310. Mechanisms governing hepadnaviral nucleocapsid assembly
  311. Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites
  312. The duck hepatitis B virus P-gene codes for protein strongly associated with the 5′-end of the viral dna minus strand
  313. Adaptation of the Hepatitis C Virus to Cell Culture
  314. Chronic hepatitis C: Portrait of a silent epidemic and the etiologic agent
  315. In Vitro Replication Models